ABT-869 a Multi-Targeted Receptor Tyrosine Kinase Inhibitor: Inhibition of FLT3 Phosphorylation and Signaling in Acute Myeloid Leukemia Running Title: ABT-869 Receptor Tyrosine Kinase Inhibitor in AML
Year: 2007
Type: conference-abstract
Authors: Neil P. Shah, Theodore B. Moore, Kathleen M. Sakamoto, Keith B. Glaser, Kresna Hartandi, Michael R. Michaelides, Steven K. Davidsen, Saul J. Priceman, Jenny Chia-Chen Chang, Katrin Albert, Jennifer J. Bouska, Donald J. Osterling, Jun Guo, Patrick A. Marcotte, Eric F. Johnson, Niru B. Soni, Deepa Shankar, Junling Li, Paul Tapang, Jennifer McCall, Lori J. Pease, Yujia Dai, Ru-Qi Wei, Hanna Daniel, Daniel H. Albert, Katrin E. Rhodes
Institution: Abbott (United States)
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W267627748